drugset / Trial / NCT01555931

Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding

NCT01555931

RandomizedParallel-groupOpen-labelPrevention

Summary

This will be a randomized clinical trial of 190 women aged 18-45 who plan to breastfeed their infant for at least 6 months and desire to use the LNG-IUS as their primary contraceptive method postpartum. The investigators will compare the frequency of breastfeeding among women receiving the levonorgestrel-releasing intrauterine system (LNG-IUS) immediately after vaginal delivery compared to 4-8 weeks later. The investigators hypothesize there will be no difference in breastfeeding prevalence between the two groups.

Timeline

Start
2012-03
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule Other

Indications

No indication recorded.